Concizumab
Product Specifications
CAS Number
1312299-39-0
Target
Others|||Factor Xa
Related Pathways
Others|||Metabolism
Purity
0.95
Bioactivity
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site. Injections of Concizumab increase thrombin in blood, thereby preventing and treating hemophilia.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034337-AP 200 µL
CTNNB1, CT (CTNNB1, CTNNB, Catenin beta-1, Beta-catenin) (AP) discontinued
Ask
View Details 